PALISADE BIO, INC. Cash and Cash Equivalents
PALISADE BIO, INC. (PALI) had Cash and Cash Equivalents of $125.17 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-10
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $125.17M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $132.63M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $133.38M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $5.23M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $125.17M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $132.63M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $133.38M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $5.23M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $5.42M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $7.23M 10-Q · filed 2026-05-12 | |
| 2024-12-31 | $9.82M 10-K · filed 2026-03-20 | |
| 2024-09-30 | $8.04M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $11.35M 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $11.28M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $12.43M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $15.31M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $16.40M 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $13.30M 10-Q · filed 2024-05-13 | |
| 2022-12-31 | $12.38M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $13.98M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $4.98M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $6.64M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $10.49M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $14.10M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $12.65M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $615.00K 10-Q · filed 2022-05-13 | $6.56M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $713.00K 10-K · filed 2022-03-17 | $10.53M 10-K · filed 2021-03-22 |
| 2020-09-30 | $751.00K 10-Q · filed 2021-11-12 | $12.65M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $1.52M 10-Q · filed 2021-08-23 | $15.83M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $10.03M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $5.11M 10-K · filed 2021-03-22 | |
| 2019-09-30 | $7.30M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $2.28M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $4.01M 10-Q · filed 2020-05-15 | |
| 2018-12-31 | $5.79M 10-Q · filed 2020-05-15 | |
| 2018-09-30 | $5.74M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $7.09M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $9.72M 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $6.67M 10-K · filed 2020-03-27 | |
| 2017-09-30 | $9.06M 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $6.44M 10-Q · filed 2018-08-13 | |
| 2017-03-31 | $11.68M 10-Q · filed 2018-05-15 | |
| 2016-12-31 | $15.19M 10-K · filed 2019-03-22 | |
| 2016-09-30 | $5.68M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $11.13M 10-Q · filed 2017-08-08 | |
| 2016-03-31 | $7.62M 10-Q · filed 2017-05-10 | |
| 2015-12-31 | $4.72M 10-K · filed 2018-04-02 | |
| 2015-09-30 | $13.13M 10-Q · filed 2016-11-08 | |
| 2015-06-30 | $8.65M 10-Q · filed 2016-08-11 | |
| 2015-03-31 | $13.59M 10-Q · filed 2016-05-09 | |
| 2014-12-31 | $12.52M 10-K · filed 2017-03-23 | |
| 2014-09-30 | $11.95M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $15.23M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | $18.34M 10-Q · filed 2015-05-08 | |
| 2013-12-31 | $16.85M 10-K · filed 2016-03-14 | |
| 2013-09-30 | $16.40M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $11.17M 10-Q · filed 2014-08-08 | |
| 2013-03-31 | $12.66M 10-Q · filed 2014-05-12 | |
| 2012-12-31 | $7.44M 10-K · filed 2016-03-14 | |
| 2012-09-30 | $9.87M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $2.54M 10-Q · filed 2013-08-08 | |
| 2012-03-31 | $5.14M 10-Q · filed 2013-05-10 | |
| 2011-12-31 | $2.35M 10-K · filed 2015-03-16 | |
| 2011-09-30 | $4.20M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $6.14M 10-Q · filed 2012-11-09 | |
| 2011-03-31 | $8.55M 10-Q · filed 2012-05-09 | |
| 2010-12-31 | $9.26M 10-K · filed 2014-03-10 | |
| 2010-09-30 | $11.59M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $14.03M 10-Q/A · filed 2011-09-23 | |
| 2009-12-31 | $2.31M 10-K · filed 2012-03-30 | |
| 2008-12-31 | $4.90M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |